Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NYLI Healthy Hearts ETF HART

The Fund seeks investment results that correspond (before fees and expenses) generally to the price and yield performance of its underlying index, the IQ Candriam Healthy Hearts Index The Fund employs a passive management ¿ or indexing ¿ investment approach designed to track the performance of the Underlying Index, which was developed by IndexIQ LLC


ARCA:HART - Post by User

Comment by Schmidon Mar 05, 2014 3:21pm
67 Views
Post# 22284782

RE:RE:RE:RE:RE:Be the first to post on this bullboard.

RE:RE:RE:RE:RE:Be the first to post on this bullboard.Option Action on ONVO

FORM 4 UNITED STATES SECURITIES AND EXCHANGE 
COMMISSION 
Washington, D.C. 20549 
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 
OF SECURITIES 
 
OMB APPROVAL 
OMB Number: 3235-0287 
Estimated average burden 
hours per response... 0.5 
 
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 
or Section 30(h) of the Investment Company Act of 1940 
 
1. Name and Address of Reporting Person * 
Murphy Keith 
2. Issuer Name and Ticker or Trading Symbol 
ORGANOVO HOLDINGS, INC. 
[ ONVO ] 
5. Relationship of Reporting Person(s) to Issuer 
(Check all applicable) 
__ X __ Director _____ 10% Owner 
__ X __ Officer (give title below) _____ Other (specify 
below) 
Chairman, CEO and President 
(Last) (First) (Middle) 
6275 NANCY RIDGE DRIVE, 
SUITE 110 
3. Date of Earliest Transaction (MM/DD/YYYY) 
2/18/2014 
(Street) 
SAN DIEGO, CA 92121 
(City) (State) (Zip) 
4. If Amendment, Date Original Filed 
(MM/DD/YYYY) 
 
6. Individual or Joint/Group Filing (Check 
Applicable Line) 
_ X _ Form filed by One Reporting Person 
___ Form filed by More than One Reporting Person 
Common Stock 
2/18/2014 
 
 S (1) 
100000 
 
D $9.8222 
(2) 5974643 D 
Common Stock 
2/19/2014 
 
 A 50000 A 
 
(3) 6024643 D 
Common Stock 
2/19/2014 
 
 F 
27307 
(4) D $9.86 5997336 
(5) D 
 
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 
1.Title of Security 
(Instr. 3) 
2. Trans. 
Date 
2A. 
Deemed 
Execution 
Date, if 
any 
3. Trans. 
Code 
(Instr. 8) 
4. Securities Acquired (A) 
or Disposed of (D) 
(Instr. 3, 4 and 5) 
5. Amount of Securities Beneficially 
Owned Following Reported Transaction(s) 
(Instr. 3 and 4) 
6. 
Ownership 
Form: 
Direct (D) 
or Indirect 
(I) (Instr. 
4) 
7. Nature 
of Indirect 
Beneficial 
Ownership 
(Instr. 4) 
Code V Amount 
(A) 
or 
(D) Price 
Stock Option (Right 
to Buy) 
(6) $9.86 
2/19/2014 
 
 A 27307 2/19/2014 
2/19/2024 
 
Common 
Stock 
27307 $0 27307 D 
Stock Option (Right 
to Buy) 
(7) $9.86 
2/19/2014 
 
 A 550000 
 
(8) 2/19/2024 
 
Common 
Stock 
550000 $0 550000 D 
 
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 
1. Title of Derivate 
Security 
(Instr. 3) 
2. 
Conversion 
or Exercise 
Price of 
Derivative 
Security 
3. Trans. 
Date 
3A. 
Deemed 
Execution 
Date, if 
any 
4. 
Trans. 
Code 
(Instr. 
8) 
5. Number of 
Derivative 
Securities 
Acquired (A) or 
Disposed of (D) 
 
(Instr. 3, 4 and 
5) 
6. Date Exercisable 
and Expiration Date 
7. Title and Amount of 
Securities Underlying 
Derivative Security 
(Instr. 3 and 4) 
8. Price of 
Derivative 
Security 
(Instr. 5) 
9. Number 
of 
derivative 
Securities 
Beneficially 
Owned 
Following 
Reported 
Transaction
(s) (Instr. 4) 
10. 
Ownership 
Form of 
Derivative 
Security: 
Direct (D) 
or Indirect 
(I) (Instr. 
4) 
11. Nature 
of Indirect 
Beneficial 
Ownership 
(Instr. 4) 
Code V (A) (D) 
Date 
Exercisable 
Expiration 
Date Title 
Amount or 
Number of 
Shares 
Explanation of Responses: 
( 1) The sale of shares was effecutated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. 
( 2) This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.75 to $9.88. 
The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC 
staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. 
( 3) In August 2012, Mr. Murphy received a grant of performance-based restricted stock units for 200,000 shares of Issuer's common stock, 
with 25% of the shares vesting upon the achievement of each of four specific performance milestones prior to December 31, 2014. On 
February 19, 2014, the Compensation Committee of the Issuer's Board of Directors determined that, as a result of the Issuer obtaining 
analyst coverage for its common stock, Mr. Murphy had achieved the third of four performance milestones and had vested in an 
<< Previous
Bullboard Posts
Next >>